Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy
Article in Journal of Neuro-Oncology (April 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Article in Journal of Neuro-Oncology (April 2024)
Article in Inflammation (April 2024)
Article in ACS Omega (March 2024)